Date posted: June 6, 2023, 6:00 am
In this episode, we compare hydrochlorothiazide and chlorthalidone, but specifically from a cardiovascular outcomes perspective when used in patients with hypertension.
Date posted: May 16, 2023, 6:00 am
In this episode, we discuss the concerns of QTc prolongation, which can cause a fatal arrhythmia called torsades de pointes (TdP). We cover the difference between QT and QTc, how to interpret a QTc (and when it is inaccurate), common medications that prolong QTc, and how pharmacists can evaluate the risk of QTc/TdP in patients who are receiving QTc-prolonging therapies.
Date posted: April 25, 2023, 6:00 am
In this episode, we will discuss the most important updates from the ľ¹ÏÖ±²¥ Diabetes Association’s 2023 Standards of Care in Diabetes.
Date posted: April 4, 2023, 6:00 am
In this episode, we review clinical pearls and common pitfalls of immunosuppression regimens for organ transplantation with a particular focus on tacrolimus and mycophenolate.
Date posted: March 14, 2023, 6:00 am
In this first ever CE episode, we discuss the A-Zs of continuous glucose monitors (CGMs).
ACPE-Accredited Pharmacist CE (1.0 hrs)
To obtain CE credit for a $5 fee, visit the following link: . Once payment is successful, you will be redirected to our CE partner (CE Impact) to complete an evaluation and to earn 1.0 hour of CE credit. CE is available for 12 months after episode publication.
Date posted: February 21, 2023, 6:00 am
In this episode, we interview Dr. Shannon Rotolo and Dr. Alex Berce regarding Illinois and Wisconsin drug repository programs – these are programs that allow certain medications to be donated to participating sites and then redistributed to patients at a very low dispensing cost.
Date posted: January 31, 2023, 6:00 am
In this episode, we discuss the evidence, safety, and place in therapy of Auvelity® (dextromethorphan-bupropion), a newly approved antidepressant with a unique mechanism of action and interesting pharmacokinetic considerations.
Date posted: January 10, 2023, 6:00 am
In this episode, we highlight important changes to the 2023 GOLD Guidelines for COPD. In particular, we discuss a revision to the GOLD group classification system and the preferred initial therapies in patients with COPD.
Date posted: December 21, 2022, 6:00 am
In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy, and guideline-directed medication therapy recommendations including the newest evidence for the use of DOACs.
Date posted: November 29, 2022, 6:00 am
In this episode, we review the management of a patient with hypokalemia, including both inpatient and outpatient supplementation with potassium chloride supplements and what dosage forms are available for potassium repletion.